PMC:7555630 / 20125-20853 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T178","span":{"begin":174,"end":192},"obj":"Disease"},{"id":"T179","span":{"begin":483,"end":491},"obj":"Disease"},{"id":"T180","span":{"begin":512,"end":530},"obj":"Disease"},{"id":"T181","span":{"begin":709,"end":727},"obj":"Disease"}],"attributes":[{"id":"A178","pred":"mondo_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/MONDO_0005395"},{"id":"A179","pred":"mondo_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A180","pred":"mondo_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/MONDO_0005395"},{"id":"A181","pred":"mondo_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/MONDO_0005395"}],"text":"5. Conclusions\nWe recognize that the major limitation of our study is the retrospective data collection from a comprehensive (hospital) data source and self-reports from our Movement Disorders Center patients. Furthermore, although our cohort is larger than others previously reported, the sample size of 36 patients still precluded us from performing multivariate adjusted analyses. Despite these limitations, our findings contribute further to understanding the clinical course of COVID-19 among patients with movement disorders. Future multicenter studies will be needed to create a large enough dataset to carry out rigorous statistical analyses to determine the specific vulnerabilities of patients with movement disorders."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T95","span":{"begin":109,"end":110},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T96","span":{"begin":305,"end":307},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T97","span":{"begin":584,"end":585},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"5. Conclusions\nWe recognize that the major limitation of our study is the retrospective data collection from a comprehensive (hospital) data source and self-reports from our Movement Disorders Center patients. Furthermore, although our cohort is larger than others previously reported, the sample size of 36 patients still precluded us from performing multivariate adjusted analyses. Despite these limitations, our findings contribute further to understanding the clinical course of COVID-19 among patients with movement disorders. Future multicenter studies will be needed to create a large enough dataset to carry out rigorous statistical analyses to determine the specific vulnerabilities of patients with movement disorders."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T127","span":{"begin":174,"end":192},"obj":"Phenotype"},{"id":"T128","span":{"begin":512,"end":530},"obj":"Phenotype"},{"id":"T129","span":{"begin":709,"end":727},"obj":"Phenotype"}],"attributes":[{"id":"A127","pred":"hp_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/HP_0100022"},{"id":"A128","pred":"hp_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/HP_0100022"},{"id":"A129","pred":"hp_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/HP_0100022"}],"text":"5. Conclusions\nWe recognize that the major limitation of our study is the retrospective data collection from a comprehensive (hospital) data source and self-reports from our Movement Disorders Center patients. Furthermore, although our cohort is larger than others previously reported, the sample size of 36 patients still precluded us from performing multivariate adjusted analyses. Despite these limitations, our findings contribute further to understanding the clinical course of COVID-19 among patients with movement disorders. Future multicenter studies will be needed to create a large enough dataset to carry out rigorous statistical analyses to determine the specific vulnerabilities of patients with movement disorders."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T117","span":{"begin":0,"end":2},"obj":"Sentence"},{"id":"T118","span":{"begin":3,"end":14},"obj":"Sentence"},{"id":"T119","span":{"begin":15,"end":209},"obj":"Sentence"},{"id":"T120","span":{"begin":210,"end":383},"obj":"Sentence"},{"id":"T121","span":{"begin":384,"end":531},"obj":"Sentence"},{"id":"T122","span":{"begin":532,"end":728},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"5. Conclusions\nWe recognize that the major limitation of our study is the retrospective data collection from a comprehensive (hospital) data source and self-reports from our Movement Disorders Center patients. Furthermore, although our cohort is larger than others previously reported, the sample size of 36 patients still precluded us from performing multivariate adjusted analyses. Despite these limitations, our findings contribute further to understanding the clinical course of COVID-19 among patients with movement disorders. Future multicenter studies will be needed to create a large enough dataset to carry out rigorous statistical analyses to determine the specific vulnerabilities of patients with movement disorders."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"704","span":{"begin":200,"end":208},"obj":"Species"},{"id":"705","span":{"begin":308,"end":316},"obj":"Species"},{"id":"706","span":{"begin":498,"end":506},"obj":"Species"},{"id":"707","span":{"begin":695,"end":703},"obj":"Species"},{"id":"708","span":{"begin":174,"end":192},"obj":"Disease"},{"id":"709","span":{"begin":483,"end":491},"obj":"Disease"},{"id":"710","span":{"begin":512,"end":530},"obj":"Disease"},{"id":"711","span":{"begin":709,"end":727},"obj":"Disease"}],"attributes":[{"id":"A704","pred":"tao:has_database_id","subj":"704","obj":"Tax:9606"},{"id":"A705","pred":"tao:has_database_id","subj":"705","obj":"Tax:9606"},{"id":"A706","pred":"tao:has_database_id","subj":"706","obj":"Tax:9606"},{"id":"A707","pred":"tao:has_database_id","subj":"707","obj":"Tax:9606"},{"id":"A708","pred":"tao:has_database_id","subj":"708","obj":"MESH:D009069"},{"id":"A709","pred":"tao:has_database_id","subj":"709","obj":"MESH:C000657245"},{"id":"A710","pred":"tao:has_database_id","subj":"710","obj":"MESH:D009069"},{"id":"A711","pred":"tao:has_database_id","subj":"711","obj":"MESH:D009069"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"5. Conclusions\nWe recognize that the major limitation of our study is the retrospective data collection from a comprehensive (hospital) data source and self-reports from our Movement Disorders Center patients. Furthermore, although our cohort is larger than others previously reported, the sample size of 36 patients still precluded us from performing multivariate adjusted analyses. Despite these limitations, our findings contribute further to understanding the clinical course of COVID-19 among patients with movement disorders. Future multicenter studies will be needed to create a large enough dataset to carry out rigorous statistical analyses to determine the specific vulnerabilities of patients with movement disorders."}